We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

MRC Technology Collaborates with RDL on Infectious Disease Diagnostics

By LabMedica International staff writers
Posted on 15 Oct 2013
The technology transfer organization, MRC Technology Ltd (London, United Kingdom) has entered into collaboration with RDL, (Glasgow, United Kingdom), developer of the RenDx multiplex assay system, to identify and design novel clinical diagnostic tests for infectious disease.

Rupert Jones, RDL’s general manager said, “RDL is delighted to be working with MRC Technology as a leader in translating basic research into commercial opportunities. MRC Technology's expertise and experience will allow us to accelerate development of our assay portfolio, enhancing the capabilities of the RenDx platform and providing end users with additional value and flexibility.”

Mike Dalrymple, MRC Technology added, “MRC Technology will build a capability in early stage translation of diagnostic opportunities from academia at our laboratory facilities in Edinburgh.”

The RenDx Multiplex Assay System provides a new approach to multiplex DNA detection. Starting from the user's existing extraction and amplification methods, the assay utilizes purpose-designed instrumentation to automate the processing and detection of up to nine targets in a single sample. The RenDx multiplex assay system is based on surface enhanced resonance Raman scattering, providing automated, multiplex, high sensitivity, in vitro screening for clinical research.

MRC Technology is an independent life science technology transfer charity, offering professional services to organizations within the academic, charity, biotechnology, and pharmaceutical sectors globally. Its goal is to ensure that innovative life science research reaches its full potential. The company provides technology transfer services, identifying and protecting research, and partnering it with industry to continue development to market. Services include IP management, research, and development for diagnostics, small molecules, and therapeutic antibodies.

Renishaw Diagnostics Ltd is a subsidiary of the Renishaw Group, a global supplier of engineering technologies, medical devices, and Raman spectroscopy systems. Renishaw's products are used in diverse applications such as machine tool automation, additive manufacturing, and medical technologies.

Related Links:
MRC Technology Ltd
RDL


New
Gold Member
Automated Clinical Chemistry Analyzer
Envoy 500+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Electrolyte Analyzer
BKE-B
New
POC Immunoassay Analyzer
Procise DX

Latest Industry News

Integrated DNA Technologies Expands into Clinical Diagnostics
15 Oct 2013  |   Industry

Co-Diagnostics Agreement Expands Commercial and Distribution Reach in South Asia
15 Oct 2013  |   Industry

Automated MSI Test Gains IVDR Certification to Guide CRC Therapy
15 Oct 2013  |   Industry



INTEGRA BIOSCIENCES AG